Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. 2531 Introduced in Senate (IS)]

<DOC>






119th CONGRESS
  1st Session
                                S. 2531

To authorize the Secretary of Health and Human Services to award grants 
 to increase early detection of and intervention for uterine fibroids, 
                        and for other purposes.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                             July 30, 2025

 Ms. Alsobrooks (for herself and Ms. Lummis) introduced the following 
  bill; which was read twice and referred to the Committee on Health, 
                     Education, Labor, and Pensions

_______________________________________________________________________

                                 A BILL


 
To authorize the Secretary of Health and Human Services to award grants 
 to increase early detection of and intervention for uterine fibroids, 
                        and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Uterine Fibroid Intervention and 
Gynecological Health Treatment Act of 2025''.

SEC. 2. RESEARCH ON UTERINE FIBROID EARLY DETECTION AND INTERVENTION.

    (a) In General.--The Secretary of Health and Human Services 
(referred to in this Act as the ``Secretary'') shall--
            (1) conduct or support research on increasing early 
        detection of, and intervention for, uterine fibroids; and
            (2) based on the results of such research and other 
        relevant information, formulate evidence-based or evidence-
        informed strategies to increase early detection in health care 
        settings.
    (b) Timeline.--The Secretary shall finalize the evidence-based or 
evidence-informed strategies required by subsection (a)(2) as 
expeditiously as possible in order to make such strategies available to 
grantees under section 3 to implement such strategies pursuant to 
section 3(b)(3).

SEC. 3. GRANTS WITH RESPECT TO UTERINE FIBROID EARLY DETECTION AND 
              INTERVENTION.

    (a) In General.--The Secretary may award grants to States for 
carrying out programs--
            (1) to increase early detection of, and intervention for, 
        uterine fibroids; and
            (2) to develop and implement public awareness and education 
        campaigns for the early detection of, and intervention for, 
        uterine fibroids.
    (b) Use of Funds.--A State receiving a grant under this section may 
use the grant for the following activities, with respect to increasing 
early detection of, and intervention for, uterine fibroids:
            (1) Screening procedures, including advanced gynecological 
        imaging, including payment for such procedures.
            (2) Patient navigation services.
            (3) Implementation of evidence-based or evidence-informed 
        strategies formulated under section 2(a)(2).
            (4) Facilitating access to health care settings.

SEC. 4. RESEARCH WITH RESPECT TO UTERINE FIBROID EARLY DETECTION AND 
              INTERVENTION.

    The Secretary may award grants to States for the purpose of 
conducting research, which may include clinical trials, related to--
            (1) disparities in pain control and management in uterine 
        fibroid surgical treatment; or
            (2) Asherman's Syndrome, intrauterine adhesions, and other 
        intrauterine conditions, as the Secretary determines 
        appropriate.

SEC. 5. REPORTS TO CONGRESS.

    (a) Reports on Grants.--Not later 2 years after the initial award 
of grants under section 2 or 3, and every 2 years thereafter, the 
Secretary shall submit to Congress, and make publicly available on the 
website of the Department of Health and Human Services--
            (1) a report summarizing the findings and results of 
        programs and activities funded through grants awarded under 
        this Act; and
            (2) a report outlining research developments and findings 
        related to--
                    (A) disparities in pain control and management in 
                uterine fibroid surgical treatment; and
                    (B) Asherman's Syndrome, intrauterine adhesions, 
                and other intrauterine conditions, as the Secretary 
                determines appropriate.
                                 <all>